Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.58268627 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.58268627 |
3 | negative regulation of cell killing (GO:0031342) | 4.50011510 |
4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.50011510 |
5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.34122350 |
6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.22875350 |
7 | regulation of RIG-I signaling pathway (GO:0039535) | 4.09956003 |
8 | NIK/NF-kappaB signaling (GO:0038061) | 3.81288483 |
9 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.75868183 |
10 | ribosomal small subunit assembly (GO:0000028) | 3.75004187 |
11 | regulation of platelet aggregation (GO:0090330) | 3.44125284 |
12 | DNA deamination (GO:0045006) | 3.44050840 |
13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.36906226 |
14 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.36183106 |
15 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.33339339 |
16 | type I interferon signaling pathway (GO:0060337) | 3.31595866 |
17 | cellular response to type I interferon (GO:0071357) | 3.31595866 |
18 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.29254721 |
19 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.28719196 |
20 | natural killer cell mediated immunity (GO:0002228) | 3.28719196 |
21 | response to type I interferon (GO:0034340) | 3.27666404 |
22 | positive regulation of granulocyte differentiation (GO:0030854) | 3.21795236 |
23 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.21282990 |
24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.21282990 |
25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.21282990 |
26 | modulation by symbiont of host immune response (GO:0052553) | 3.21282990 |
27 | positive regulation by symbiont of host defense response (GO:0052509) | 3.21282990 |
28 | modulation by symbiont of host defense response (GO:0052031) | 3.21282990 |
29 | regulation of gamma-delta T cell activation (GO:0046643) | 3.20138165 |
30 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.15946274 |
31 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.14207427 |
32 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.11443330 |
33 | macrophage activation involved in immune response (GO:0002281) | 3.09957625 |
34 | immunoglobulin mediated immune response (GO:0016064) | 3.08640388 |
35 | response to interferon-alpha (GO:0035455) | 3.07155256 |
36 | DNA replication initiation (GO:0006270) | 3.04278115 |
37 | myeloid dendritic cell activation (GO:0001773) | 3.04079874 |
38 | neutrophil activation involved in immune response (GO:0002283) | 3.03117705 |
39 | negative regulation of viral genome replication (GO:0045071) | 3.00225998 |
40 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.00092275 |
41 | positive regulation of interferon-alpha production (GO:0032727) | 2.99426491 |
42 | response to interleukin-15 (GO:0070672) | 2.99282877 |
43 | myeloid dendritic cell differentiation (GO:0043011) | 2.98359742 |
44 | DNA strand elongation (GO:0022616) | 2.98154110 |
45 | telomere maintenance via recombination (GO:0000722) | 2.98079164 |
46 | DNA replication checkpoint (GO:0000076) | 2.97508933 |
47 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.96547601 |
48 | B cell receptor signaling pathway (GO:0050853) | 2.96232262 |
49 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.95982880 |
50 | response to interferon-beta (GO:0035456) | 2.95932714 |
51 | meiotic chromosome segregation (GO:0045132) | 2.95106344 |
52 | purine nucleobase biosynthetic process (GO:0009113) | 2.94594255 |
53 | detection of molecule of bacterial origin (GO:0032490) | 2.94485540 |
54 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.88029876 |
55 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.88029876 |
56 | detection of other organism (GO:0098543) | 2.85749613 |
57 | positive regulation of mast cell activation (GO:0033005) | 2.84717218 |
58 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.84673794 |
59 | protein localization to kinetochore (GO:0034501) | 2.84661667 |
60 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.81306250 |
61 | cellular response to interferon-beta (GO:0035458) | 2.80093379 |
62 | regulation of interferon-alpha production (GO:0032647) | 2.79570370 |
63 | hepatocyte apoptotic process (GO:0097284) | 2.79040025 |
64 | negative regulation of interleukin-12 production (GO:0032695) | 2.78950859 |
65 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.77663726 |
66 | negative T cell selection (GO:0043383) | 2.76047436 |
67 | nucleobase biosynthetic process (GO:0046112) | 2.75612023 |
68 | negative regulation of T cell mediated immunity (GO:0002710) | 2.74775563 |
69 | microglial cell activation (GO:0001774) | 2.74575105 |
70 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.73712470 |
71 | cellular extravasation (GO:0045123) | 2.73499385 |
72 | mitotic recombination (GO:0006312) | 2.72685538 |
73 | B cell mediated immunity (GO:0019724) | 2.70860725 |
74 | negative thymic T cell selection (GO:0045060) | 2.70835916 |
75 | granulocyte activation (GO:0036230) | 2.70139793 |
76 | germinal center formation (GO:0002467) | 2.70098410 |
77 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.69867155 |
78 | regulation of response to interferon-gamma (GO:0060330) | 2.68627929 |
79 | T cell migration (GO:0072678) | 2.67756059 |
80 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.67587067 |
81 | maturation of SSU-rRNA (GO:0030490) | 2.66502289 |
82 | protein localization to chromosome, centromeric region (GO:0071459) | 2.66097203 |
83 | detection of external biotic stimulus (GO:0098581) | 2.65454119 |
84 | necroptotic process (GO:0070266) | 2.65244686 |
85 | detection of bacterium (GO:0016045) | 2.64792551 |
86 | positive regulation of macrophage differentiation (GO:0045651) | 2.64633385 |
87 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.62485224 |
88 | regulation of regulatory T cell differentiation (GO:0045589) | 2.62282492 |
89 | mitotic metaphase plate congression (GO:0007080) | 2.60836565 |
90 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.59759162 |
91 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.59272626 |
92 | regulation of platelet activation (GO:0010543) | 2.58299497 |
93 | myeloid cell activation involved in immune response (GO:0002275) | 2.57937623 |
94 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.57880667 |
95 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.57158280 |
96 | response to host immune response (GO:0052572) | 2.57158280 |
97 | cellular response to interleukin-15 (GO:0071350) | 2.57005281 |
98 | megakaryocyte development (GO:0035855) | 2.56444849 |
99 | endosome to pigment granule transport (GO:0043485) | 2.56043946 |
100 | endosome to melanosome transport (GO:0035646) | 2.56043946 |
101 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.55412012 |
102 | defense response to protozoan (GO:0042832) | 2.55118413 |
103 | cellular response to exogenous dsRNA (GO:0071360) | 2.54712208 |
104 | positive regulation of B cell differentiation (GO:0045579) | 2.54169527 |
105 | positive regulation of interferon-beta production (GO:0032728) | 2.53096577 |
106 | dendritic cell differentiation (GO:0097028) | 2.52457980 |
107 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.51839211 |
108 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.51367602 |
109 | CENP-A containing nucleosome assembly (GO:0034080) | 2.51261713 |
110 | leukocyte mediated cytotoxicity (GO:0001909) | 2.51017996 |
111 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.49242068 |
112 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.47058947 |
113 | chromatin remodeling at centromere (GO:0031055) | 2.46420675 |
114 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.46329698 |
115 | response to host (GO:0075136) | 2.46329698 |
116 | response to host defenses (GO:0052200) | 2.46329698 |
117 | regulation of natural killer cell activation (GO:0032814) | 2.46313152 |
118 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.45643329 |
119 | regulation of natural killer cell differentiation (GO:0032823) | 2.45456440 |
120 | positive regulation of receptor recycling (GO:0001921) | 2.44924476 |
121 | positive regulation of natural killer cell activation (GO:0032816) | 2.44721694 |
122 | macrophage activation (GO:0042116) | 2.44095105 |
123 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.43227628 |
124 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.43227628 |
125 | positive regulation of defense response to virus by host (GO:0002230) | 2.42632330 |
126 | positive regulation of type 2 immune response (GO:0002830) | 2.41811849 |
127 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.41301446 |
128 | cellular response to zinc ion (GO:0071294) | 2.40577794 |
129 | T-helper 1 type immune response (GO:0042088) | 2.39722854 |
130 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.39418072 |
131 | regulation of defense response to virus by host (GO:0050691) | 2.39125550 |
132 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.38376511 |
133 | positive regulation of B cell mediated immunity (GO:0002714) | 2.38376511 |
134 | regulation of mast cell degranulation (GO:0043304) | 2.38335550 |
135 | DNA synthesis involved in DNA repair (GO:0000731) | 2.37359294 |
136 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.37192487 |
137 | metaphase plate congression (GO:0051310) | 2.37060289 |
138 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.36992873 |
139 | protein K6-linked ubiquitination (GO:0085020) | 2.36902423 |
140 | thrombin receptor signaling pathway (GO:0070493) | 2.36894454 |
141 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.36812330 |
142 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.36744388 |
143 | tolerance induction (GO:0002507) | 2.34864448 |
144 | mitotic nuclear envelope disassembly (GO:0007077) | 2.34775726 |
145 | positive regulation of Rap GTPase activity (GO:0032854) | 2.34404414 |
146 | response to protozoan (GO:0001562) | 2.34097243 |
147 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.33938977 |
148 | neutrophil activation (GO:0042119) | 2.33847518 |
149 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.33674866 |
150 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.33275714 |
151 | ribosome biogenesis (GO:0042254) | 2.32229257 |
152 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.31672594 |
153 | regulation of necroptotic process (GO:0060544) | 2.31483220 |
154 | negative regulation of interleukin-17 production (GO:0032700) | 2.31378901 |
155 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.31198330 |
156 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.30895906 |
157 | positive regulation of antigen processing and presentation (GO:0002579) | 2.30415172 |
158 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.30364804 |
159 | positive T cell selection (GO:0043368) | 2.30313722 |
160 | telomere maintenance via telomere lengthening (GO:0010833) | 2.30072509 |
161 | regulation of T cell tolerance induction (GO:0002664) | 2.29988839 |
162 | natural killer cell differentiation (GO:0001779) | 2.29446696 |
163 | T cell selection (GO:0045058) | 2.29403519 |
164 | response to peptidoglycan (GO:0032494) | 2.28952703 |
165 | DNA replication-independent nucleosome organization (GO:0034724) | 2.28701309 |
166 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.28701309 |
167 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.28195610 |
168 | cellular response to ethanol (GO:0071361) | 2.27873852 |
169 | positive thymic T cell selection (GO:0045059) | 2.27773048 |
170 | regulation of mast cell activation (GO:0033003) | 2.27474515 |
171 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.27340860 |
172 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.26501771 |
173 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.26188835 |
174 | piRNA metabolic process (GO:0034587) | 2.26043552 |
175 | T cell apoptotic process (GO:0070231) | 2.25273139 |
176 | formation of translation preinitiation complex (GO:0001731) | 2.24920068 |
177 | positive regulation of type I interferon production (GO:0032481) | 2.24901168 |
178 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.23846096 |
179 | translesion synthesis (GO:0019985) | 2.23820726 |
180 | dendritic cell chemotaxis (GO:0002407) | 2.23735821 |
181 | positive regulation of blood coagulation (GO:0030194) | 2.23313860 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.74036385 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.22045341 |
3 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.30098906 |
4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.23771747 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.10400880 |
6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.76990547 |
7 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.73667055 |
8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.65595669 |
9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.65459366 |
10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.64335381 |
11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.43608013 |
12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.35676913 |
13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.33173315 |
14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.28225567 |
15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.27196545 |
16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.25441602 |
17 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.11372947 |
18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.10683678 |
19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.10462431 |
20 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.05305876 |
21 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.03988521 |
22 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.02472717 |
23 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.02449160 |
24 | GATA1_19941826_ChIP-Seq_K562_Human | 2.00808075 |
25 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.00411039 |
26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.99985044 |
27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.99338851 |
28 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.98300597 |
29 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.96897701 |
30 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.91826901 |
31 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.91061967 |
32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.90929126 |
33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88647349 |
34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.85286785 |
35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.85012429 |
36 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.84402642 |
37 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83568942 |
38 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.80158772 |
39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79972055 |
40 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.79656035 |
41 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.77530237 |
42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.71169231 |
43 | GATA2_19941826_ChIP-Seq_K562_Human | 1.70961869 |
44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.70535309 |
45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69526719 |
46 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.68600980 |
47 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.68522141 |
48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.68395208 |
49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67606752 |
50 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.66709818 |
51 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.66260326 |
52 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.66196077 |
53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.65399040 |
54 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.64979896 |
55 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.64538856 |
56 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62949309 |
57 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.62677711 |
58 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.60666201 |
59 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.60300183 |
60 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.59849868 |
61 | MYC_22102868_ChIP-Seq_BL_Human | 1.59747962 |
62 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.58282897 |
63 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57547003 |
64 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.55848269 |
65 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.55520951 |
66 | MYB_26560356_Chip-Seq_TH2_Human | 1.55348133 |
67 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.54930600 |
68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.50432740 |
69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50249479 |
70 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48452495 |
71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.46280616 |
72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.46217684 |
73 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.45495297 |
74 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.45278915 |
75 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42216467 |
76 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.41291786 |
77 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.40825957 |
78 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.40786081 |
79 | MYB_26560356_Chip-Seq_TH1_Human | 1.39988902 |
80 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.36821985 |
81 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.34929963 |
82 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33641665 |
83 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.33141546 |
84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.33051710 |
85 | MAF_26560356_Chip-Seq_TH1_Human | 1.32872796 |
86 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.30386837 |
87 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.29892570 |
88 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26418144 |
89 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25202685 |
90 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.22936027 |
91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22710729 |
92 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.21568177 |
93 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.21488041 |
94 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.20690176 |
95 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20663285 |
96 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20038284 |
97 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.16693400 |
98 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16360302 |
99 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.15848725 |
100 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15507217 |
101 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.14990418 |
102 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.12754452 |
103 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.12710457 |
104 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.11715678 |
105 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11571204 |
106 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.11213079 |
107 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.11162648 |
108 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10869396 |
109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09333139 |
110 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09311397 |
111 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08428877 |
112 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07887450 |
113 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.07741223 |
114 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07687635 |
115 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.07452670 |
116 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05567408 |
117 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.04457213 |
118 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.04159506 |
119 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.03500345 |
120 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.03262209 |
121 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.03125695 |
122 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.03097443 |
123 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.02846505 |
124 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02023626 |
125 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99702475 |
126 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99231920 |
127 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98536559 |
128 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98507601 |
129 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.98398714 |
130 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97860835 |
131 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97196053 |
132 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96043445 |
133 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95870397 |
134 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94651398 |
135 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94224299 |
136 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94045966 |
137 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93556220 |
138 | UTX_26944678_Chip-Seq_JUKART_Human | 0.93375390 |
139 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.93174201 |
140 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92639462 |
141 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.92376294 |
142 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.91372505 |
143 | MAF_26560356_Chip-Seq_TH2_Human | 0.90931401 |
144 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.90326480 |
145 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90043059 |
146 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89950825 |
147 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.88259291 |
148 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87779066 |
149 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87779066 |
150 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85954544 |
151 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.85741935 |
152 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.82142271 |
153 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.80008829 |
154 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79582155 |
155 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.79415244 |
156 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79337641 |
157 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78855335 |
158 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78365484 |
159 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.77474304 |
160 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77391731 |
161 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76130616 |
162 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.75219862 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.00898394 |
2 | MP0009785_altered_susceptibility_to | 3.17436021 |
3 | MP0000685_abnormal_immune_system | 3.10213363 |
4 | MP0003693_abnormal_embryo_hatching | 2.97376485 |
5 | MP0005671_abnormal_response_to | 2.83794901 |
6 | MP0003300_gastrointestinal_ulcer | 2.81616126 |
7 | MP0002396_abnormal_hematopoietic_system | 2.70337683 |
8 | MP0010094_abnormal_chromosome_stability | 2.62826852 |
9 | MP0002148_abnormal_hypersensitivity_rea | 2.57297548 |
10 | MP0008057_abnormal_DNA_replication | 2.56394888 |
11 | MP0008004_abnormal_stomach_pH | 2.42475741 |
12 | MP0003436_decreased_susceptibility_to | 2.36051474 |
13 | MP0005025_abnormal_response_to | 2.30811117 |
14 | MP0005000_abnormal_immune_tolerance | 2.24832487 |
15 | MP0001800_abnormal_humoral_immune | 2.20974462 |
16 | MP0003763_abnormal_thymus_physiology | 2.20633776 |
17 | MP0003656_abnormal_erythrocyte_physiolo | 2.19772192 |
18 | MP0001790_abnormal_immune_system | 2.19186949 |
19 | MP0005387_immune_system_phenotype | 2.19186949 |
20 | MP0002166_altered_tumor_susceptibility | 2.17498657 |
21 | MP0004510_myositis | 2.12177029 |
22 | MP0002452_abnormal_antigen_presenting | 2.11095562 |
23 | MP0003077_abnormal_cell_cycle | 2.10124999 |
24 | MP0002723_abnormal_immune_serum | 2.09319425 |
25 | MP0004957_abnormal_blastocyst_morpholog | 2.02856195 |
26 | MP0002398_abnormal_bone_marrow | 2.02203833 |
27 | MP0001819_abnormal_immune_cell | 2.00963451 |
28 | MP0002420_abnormal_adaptive_immunity | 1.99228470 |
29 | MP0009333_abnormal_splenocyte_physiolog | 1.97333575 |
30 | MP0002006_tumorigenesis | 1.97126308 |
31 | MP0001853_heart_inflammation | 1.95310059 |
32 | MP0001545_abnormal_hematopoietic_system | 1.94283486 |
33 | MP0005397_hematopoietic_system_phenotyp | 1.94283486 |
34 | MP0008007_abnormal_cellular_replicative | 1.93078687 |
35 | MP0008058_abnormal_DNA_repair | 1.91134781 |
36 | MP0002419_abnormal_innate_immunity | 1.89788034 |
37 | MP0004808_abnormal_hematopoietic_stem | 1.88602137 |
38 | MP0003111_abnormal_nucleus_morphology | 1.87988232 |
39 | MP0003183_abnormal_peptide_metabolism | 1.84427852 |
40 | MP0000716_abnormal_immune_system | 1.81749799 |
41 | MP0008877_abnormal_DNA_methylation | 1.74161607 |
42 | MP0003724_increased_susceptibility_to | 1.67504988 |
43 | MP0002429_abnormal_blood_cell | 1.62102981 |
44 | MP0000689_abnormal_spleen_morphology | 1.61280344 |
45 | MP0010307_abnormal_tumor_latency | 1.58989760 |
46 | MP0002722_abnormal_immune_system | 1.57015956 |
47 | MP0002405_respiratory_system_inflammati | 1.56813541 |
48 | MP0005464_abnormal_platelet_physiology | 1.52608393 |
49 | MP0002139_abnormal_hepatobiliary_system | 1.51108310 |
50 | MP0010155_abnormal_intestine_physiology | 1.50513440 |
51 | MP0003646_muscle_fatigue | 1.49721811 |
52 | MP0002877_abnormal_melanocyte_morpholog | 1.44193487 |
53 | MP0003186_abnormal_redox_activity | 1.38276727 |
54 | MP0000490_abnormal_crypts_of | 1.38110898 |
55 | MP0001845_abnormal_inflammatory_respons | 1.37470911 |
56 | MP0006082_CNS_inflammation | 1.36796912 |
57 | MP0004947_skin_inflammation | 1.34175304 |
58 | MP0001851_eye_inflammation | 1.33279000 |
59 | MP0002998_abnormal_bone_remodeling | 1.32938813 |
60 | MP0005310_abnormal_salivary_gland | 1.31024719 |
61 | MP0003075_altered_response_to | 1.29014528 |
62 | MP0008469_abnormal_protein_level | 1.28795858 |
63 | MP0000858_altered_metastatic_potential | 1.27714270 |
64 | MP0003091_abnormal_cell_migration | 1.25962193 |
65 | MP0008260_abnormal_autophagy | 1.25954344 |
66 | MP0000703_abnormal_thymus_morphology | 1.25547258 |
67 | MP0002019_abnormal_tumor_incidence | 1.22328187 |
68 | MP0003690_abnormal_glial_cell | 1.22109073 |
69 | MP0003252_abnormal_bile_duct | 1.19474917 |
70 | MP0003045_fibrosis | 1.17844791 |
71 | MP0009840_abnormal_foam_cell | 1.15832454 |
72 | MP0004782_abnormal_surfactant_physiolog | 1.15263794 |
73 | MP0004484_altered_response_of | 1.12606755 |
74 | MP0005166_decreased_susceptibility_to | 1.10812368 |
75 | MP0004130_abnormal_muscle_cell | 1.10422390 |
76 | MP0004883_abnormal_blood_vessel | 1.09840943 |
77 | MP0003448_altered_tumor_morphology | 1.08321391 |
78 | MP0000313_abnormal_cell_death | 1.07431898 |
79 | MP0005174_abnormal_tail_pigmentation | 1.04263396 |
80 | MP0003221_abnormal_cardiomyocyte_apopto | 1.03685324 |
81 | MP0003786_premature_aging | 1.02068218 |
82 | MP0005164_abnormal_response_to | 1.01682835 |
83 | MP0000249_abnormal_blood_vessel | 1.00847013 |
84 | MP0002332_abnormal_exercise_endurance | 1.00521496 |
85 | MP0004036_abnormal_muscle_relaxation | 1.00509533 |
86 | MP0003566_abnormal_cell_adhesion | 0.99927595 |
87 | MP0010352_gastrointestinal_tract_polyps | 0.99821601 |
88 | MP0004381_abnormal_hair_follicle | 0.98920278 |
89 | MP0002138_abnormal_hepatobiliary_system | 0.98699444 |
90 | MP0001873_stomach_inflammation | 0.97453706 |
91 | MP0000350_abnormal_cell_proliferation | 0.96952443 |
92 | MP0001533_abnormal_skeleton_physiology | 0.95998417 |
93 | MP0009764_decreased_sensitivity_to | 0.95657524 |
94 | MP0005365_abnormal_bile_salt | 0.95072343 |
95 | MP0010329_abnormal_lipoprotein_level | 0.93921565 |
96 | MP0002163_abnormal_gland_morphology | 0.92956820 |
97 | MP0003172_abnormal_lysosome_physiology | 0.92890089 |
98 | MP0003866_abnormal_defecation | 0.92409742 |
99 | MP0004084_abnormal_cardiac_muscle | 0.91644554 |
100 | MP0005058_abnormal_lysosome_morphology | 0.88226034 |
101 | MP0001348_abnormal_lacrimal_gland | 0.88169089 |
102 | MP0000343_altered_response_to | 0.87889360 |
103 | MP0006054_spinal_hemorrhage | 0.87340073 |
104 | MP0005167_abnormal_blood-brain_barrier | 0.86563992 |
105 | MP0008874_decreased_physiological_sensi | 0.86178096 |
106 | MP0009278_abnormal_bone_marrow | 0.86016401 |
107 | MP0005165_increased_susceptibility_to | 0.85363126 |
108 | MP0003828_pulmonary_edema | 0.83514402 |
109 | MP0005085_abnormal_gallbladder_physiolo | 0.81852311 |
110 | MP0003453_abnormal_keratinocyte_physiol | 0.81391099 |
111 | MP0003303_peritoneal_inflammation | 0.81175682 |
112 | MP0000604_amyloidosis | 0.80871979 |
113 | MP0006036_abnormal_mitochondrial_physio | 0.79427862 |
114 | MP0009763_increased_sensitivity_to | 0.78467204 |
115 | MP0001765_abnormal_ion_homeostasis | 0.78211579 |
116 | MP0001764_abnormal_homeostasis | 0.76942338 |
117 | MP0000609_abnormal_liver_physiology | 0.75157898 |
118 | MP0001730_embryonic_growth_arrest | 0.74796425 |
119 | MP0002210_abnormal_sex_determination | 0.74434023 |
120 | MP0001663_abnormal_digestive_system | 0.74427375 |
121 | MP0001929_abnormal_gametogenesis | 0.74397941 |
122 | MP0002009_preneoplasia | 0.73734659 |
123 | MP0002277_abnormal_respiratory_mucosa | 0.73701689 |
124 | MP0008932_abnormal_embryonic_tissue | 0.72841915 |
125 | MP0003191_abnormal_cellular_cholesterol | 0.72481432 |
126 | MP0003879_abnormal_hair_cell | 0.71619172 |
127 | MP0005666_abnormal_adipose_tissue | 0.71385592 |
128 | MP0005023_abnormal_wound_healing | 0.70818801 |
129 | MP0002132_abnormal_respiratory_system | 0.69349409 |
130 | MP0000465_gastrointestinal_hemorrhage | 0.68383763 |
131 | MP0005451_abnormal_body_composition | 0.67710353 |
132 | MP0005075_abnormal_melanosome_morpholog | 0.66653287 |
133 | MP0003943_abnormal_hepatobiliary_system | 0.66220240 |
134 | MP0005621_abnormal_cell_physiology | 0.64732948 |
135 | MP0003984_embryonic_growth_retardation | 0.64350705 |
136 | MP0001119_abnormal_female_reproductive | 0.62147926 |
137 | MP0000358_abnormal_cell_content/ | 0.61652842 |
138 | MP0002088_abnormal_embryonic_growth/wei | 0.60687057 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Prolonged bleeding time (HP:0003010) | 5.17090560 |
2 | Thrombocytosis (HP:0001894) | 4.46085143 |
3 | Gingival bleeding (HP:0000225) | 4.31545903 |
4 | Menorrhagia (HP:0000132) | 4.05645934 |
5 | Abnormal platelet volume (HP:0011876) | 3.99866791 |
6 | Purpura (HP:0000979) | 3.98771904 |
7 | Increased mean platelet volume (HP:0011877) | 3.89926132 |
8 | Chronic otitis media (HP:0000389) | 3.86557368 |
9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.84901716 |
10 | Recurrent bacterial skin infections (HP:0005406) | 3.82174737 |
11 | Recurrent abscess formation (HP:0002722) | 3.79857551 |
12 | Spontaneous hematomas (HP:0007420) | 3.63622669 |
13 | Recurrent viral infections (HP:0004429) | 3.53366312 |
14 | Myositis (HP:0100614) | 3.52069670 |
15 | Eczematoid dermatitis (HP:0000976) | 3.46981502 |
16 | Recurrent fungal infections (HP:0002841) | 3.33739121 |
17 | Birth length less than 3rd percentile (HP:0003561) | 3.18110152 |
18 | Stomatitis (HP:0010280) | 3.14839138 |
19 | Aplastic anemia (HP:0001915) | 3.12201820 |
20 | Recurrent bronchitis (HP:0002837) | 3.08711813 |
21 | Increased IgM level (HP:0003496) | 3.03683869 |
22 | Nasal polyposis (HP:0100582) | 2.96184093 |
23 | Autoimmune thrombocytopenia (HP:0001973) | 2.91706431 |
24 | IgM deficiency (HP:0002850) | 2.81266436 |
25 | Abnormal number of erythroid precursors (HP:0012131) | 2.80182327 |
26 | Mediastinal lymphadenopathy (HP:0100721) | 2.79534651 |
27 | Abnormality of the common coagulation pathway (HP:0010990) | 2.77291344 |
28 | IgG deficiency (HP:0004315) | 2.77043700 |
29 | Abnormal spermatogenesis (HP:0008669) | 2.76989722 |
30 | Abnormality of macrophages (HP:0004311) | 2.75328269 |
31 | Acute myeloid leukemia (HP:0004808) | 2.75306754 |
32 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.70343912 |
33 | Acanthocytosis (HP:0001927) | 2.70019363 |
34 | Abnormality of T cell physiology (HP:0011840) | 2.69833010 |
35 | Hypergammaglobulinemia (HP:0010702) | 2.68865906 |
36 | Amaurosis fugax (HP:0100576) | 2.68167949 |
37 | Poikilocytosis (HP:0004447) | 2.66254212 |
38 | Petechiae (HP:0000967) | 2.63120422 |
39 | Abnormality of the nasal mucosa (HP:0000433) | 2.62957617 |
40 | Basal ganglia calcification (HP:0002135) | 2.62674462 |
41 | Recurrent skin infections (HP:0001581) | 2.60431787 |
42 | Chromsome breakage (HP:0040012) | 2.58883778 |
43 | Vasculitis (HP:0002633) | 2.57058707 |
44 | Reticulocytopenia (HP:0001896) | 2.56724810 |
45 | Joint swelling (HP:0001386) | 2.54794017 |
46 | Abnormality of T cells (HP:0002843) | 2.52330884 |
47 | Orchitis (HP:0100796) | 2.52172162 |
48 | Impaired platelet aggregation (HP:0003540) | 2.51322626 |
49 | Abnormal platelet function (HP:0011869) | 2.51322626 |
50 | Optic neuritis (HP:0100653) | 2.50510851 |
51 | Retrobulbar optic neuritis (HP:0100654) | 2.50510851 |
52 | Panhypogammaglobulinemia (HP:0003139) | 2.50430255 |
53 | Hyperlipoproteinemia (HP:0010980) | 2.50081816 |
54 | Granulocytopenia (HP:0001913) | 2.47989964 |
55 | Reduced antithrombin III activity (HP:0001976) | 2.46389365 |
56 | Eosinophilia (HP:0001880) | 2.46180507 |
57 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.45088939 |
58 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.43958678 |
59 | B lymphocytopenia (HP:0010976) | 2.40280664 |
60 | Abnormality of B cell number (HP:0010975) | 2.40280664 |
61 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.37910560 |
62 | Arterial thrombosis (HP:0004420) | 2.37376149 |
63 | Gastrointestinal infarctions (HP:0005244) | 2.37328293 |
64 | Lymphoma (HP:0002665) | 2.37128541 |
65 | Type I transferrin isoform profile (HP:0003642) | 2.36727181 |
66 | Keratoconjunctivitis sicca (HP:0001097) | 2.36266038 |
67 | Abnormality of the prostate (HP:0008775) | 2.35824813 |
68 | Pulmonary infiltrates (HP:0002113) | 2.35616641 |
69 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.35188864 |
70 | Recurrent cutaneous fungal infections (HP:0011370) | 2.35188864 |
71 | Hypoplasia of the thymus (HP:0000778) | 2.35068296 |
72 | Chest pain (HP:0100749) | 2.34948460 |
73 | Azoospermia (HP:0000027) | 2.33924415 |
74 | Episodic fever (HP:0001954) | 2.30656975 |
75 | Myelodysplasia (HP:0002863) | 2.30580659 |
76 | Polycythemia (HP:0001901) | 2.30210049 |
77 | Pulmonary embolism (HP:0002204) | 2.28367117 |
78 | Entropion (HP:0000621) | 2.27476184 |
79 | Inflammation of the large intestine (HP:0002037) | 2.27451008 |
80 | IgA deficiency (HP:0002720) | 2.26085180 |
81 | Poikiloderma (HP:0001029) | 2.23226297 |
82 | Dysostosis multiplex (HP:0000943) | 2.21904781 |
83 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.21664301 |
84 | Abnormality of the anterior horn cell (HP:0006802) | 2.21572550 |
85 | Degeneration of anterior horn cells (HP:0002398) | 2.21572550 |
86 | Leukocytosis (HP:0001974) | 2.19636442 |
87 | Abnormality of eosinophils (HP:0001879) | 2.19579652 |
88 | Abnormality of T cell number (HP:0011839) | 2.17671289 |
89 | Oral leukoplakia (HP:0002745) | 2.17439830 |
90 | Gingivitis (HP:0000230) | 2.17046084 |
91 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.15891407 |
92 | Chronic obstructive pulmonary disease (HP:0006510) | 2.15850514 |
93 | Obstructive lung disease (HP:0006536) | 2.15850514 |
94 | Abnormality of chromosome stability (HP:0003220) | 2.15089979 |
95 | Autoimmune hemolytic anemia (HP:0001890) | 2.13983649 |
96 | Gastrointestinal inflammation (HP:0004386) | 2.13046433 |
97 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.12911716 |
98 | Periodontitis (HP:0000704) | 2.12697571 |
99 | Abnormality of the preputium (HP:0100587) | 2.12271059 |
100 | Colitis (HP:0002583) | 2.12122285 |
101 | Keratoconjunctivitis (HP:0001096) | 2.10523574 |
102 | Conjunctival telangiectasia (HP:0000524) | 2.10061959 |
103 | Meningitis (HP:0001287) | 2.09418323 |
104 | Encephalitis (HP:0002383) | 2.09391651 |
105 | Chronic diarrhea (HP:0002028) | 2.06733369 |
106 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.06544523 |
107 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.06544523 |
108 | Interstitial pulmonary disease (HP:0006530) | 2.05517565 |
109 | Papilledema (HP:0001085) | 2.04745561 |
110 | Exertional dyspnea (HP:0002875) | 2.04723870 |
111 | Osteomyelitis (HP:0002754) | 2.03875221 |
112 | Breast hypoplasia (HP:0003187) | 2.03415744 |
113 | Cellulitis (HP:0100658) | 2.03412676 |
114 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.02885194 |
115 | Albinism (HP:0001022) | 2.02841815 |
116 | Pancytopenia (HP:0001876) | 2.02584844 |
117 | Neutropenia (HP:0001875) | 2.01919144 |
118 | T lymphocytopenia (HP:0005403) | 2.01273394 |
119 | Lymphopenia (HP:0001888) | 2.01104888 |
120 | Increased IgE level (HP:0003212) | 2.00569876 |
121 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.00449024 |
122 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.00449024 |
123 | Abnormality of glycolipid metabolism (HP:0010969) | 2.00449024 |
124 | Hemoptysis (HP:0002105) | 1.99894961 |
125 | Cleft eyelid (HP:0000625) | 1.98948737 |
126 | Slow saccadic eye movements (HP:0000514) | 1.98743033 |
127 | Abnormality of iron homeostasis (HP:0011031) | 1.98390117 |
128 | Pulmonary fibrosis (HP:0002206) | 1.97756239 |
129 | Acute hepatic failure (HP:0006554) | 1.97670955 |
130 | Muscle fiber atrophy (HP:0100295) | 1.97334253 |
131 | Bruising susceptibility (HP:0000978) | 1.96977796 |
132 | Hypochromic microcytic anemia (HP:0004840) | 1.95880935 |
133 | Gastrointestinal stroma tumor (HP:0100723) | 1.95497735 |
134 | 11 pairs of ribs (HP:0000878) | 1.95120939 |
135 | Mitral stenosis (HP:0001718) | 1.94480265 |
136 | Joint hemorrhage (HP:0005261) | 1.93808295 |
137 | Epistaxis (HP:0000421) | 1.93232741 |
138 | Gangrene (HP:0100758) | 1.92542801 |
139 | Fatigue (HP:0012378) | 1.92280429 |
140 | Type 2 muscle fiber atrophy (HP:0003554) | 1.91551625 |
141 | Clubbing of toes (HP:0100760) | 1.91489983 |
142 | Papillary thyroid carcinoma (HP:0002895) | 1.91185907 |
143 | Myocardial infarction (HP:0001658) | 1.91076122 |
144 | Pustule (HP:0200039) | 1.91075436 |
145 | Poor head control (HP:0002421) | 1.90157193 |
146 | Pallor (HP:0000980) | 1.89602190 |
147 | Subaortic stenosis (HP:0001682) | 1.89488359 |
148 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.89488359 |
149 | Bone marrow hypocellularity (HP:0005528) | 1.89361885 |
150 | Bronchitis (HP:0012387) | 1.88310266 |
151 | Leukopenia (HP:0001882) | 1.85959419 |
152 | Urticaria (HP:0001025) | 1.84721418 |
153 | Microcytic anemia (HP:0001935) | 1.83382156 |
154 | Thrombophlebitis (HP:0004418) | 1.82915142 |
155 | Vertigo (HP:0002321) | 1.81644277 |
156 | Arthralgia (HP:0002829) | 1.79096506 |
157 | Hematochezia (HP:0002573) | 1.78568683 |
158 | Peritonitis (HP:0002586) | 1.78431177 |
159 | Glomerulopathy (HP:0100820) | 1.77233734 |
160 | Hyporeflexia of lower limbs (HP:0002600) | 1.77112023 |
161 | Testicular neoplasm (HP:0010788) | 1.77060629 |
Rank | Gene Set | Z-score |
---|---|---|
1 | WEE1 | 3.21829636 |
2 | JAK3 | 3.02780908 |
3 | ACVR1B | 2.95983298 |
4 | MAP3K14 | 2.81843754 |
5 | NME2 | 2.80865370 |
6 | TYK2 | 2.78616521 |
7 | BMPR2 | 2.70637291 |
8 | PRPF4B | 2.52808775 |
9 | KIT | 2.34105313 |
10 | PIM2 | 2.23792273 |
11 | MAP4K1 | 2.17491248 |
12 | NEK2 | 2.16825962 |
13 | TBK1 | 2.16372223 |
14 | FGFR3 | 2.15466187 |
15 | FLT3 | 2.05722531 |
16 | BRSK2 | 2.05283861 |
17 | IRAK4 | 2.05227727 |
18 | IKBKB | 1.97893633 |
19 | RPS6KA4 | 1.88677678 |
20 | NEK9 | 1.84434157 |
21 | IKBKE | 1.83932784 |
22 | IRAK3 | 1.71776125 |
23 | EIF2AK1 | 1.67832799 |
24 | CDC7 | 1.66094311 |
25 | CSK | 1.64218673 |
26 | PLK4 | 1.63234738 |
27 | PIK3CG | 1.62256380 |
28 | TEC | 1.59757901 |
29 | VRK1 | 1.55300936 |
30 | BUB1 | 1.52799180 |
31 | TXK | 1.52766779 |
32 | BTK | 1.48644151 |
33 | MAP3K2 | 1.48594448 |
34 | CHUK | 1.45735638 |
35 | STK4 | 1.42499081 |
36 | GRK6 | 1.41141755 |
37 | MAP3K3 | 1.36981652 |
38 | ERN1 | 1.36058014 |
39 | PIM1 | 1.33325531 |
40 | EIF2AK3 | 1.32839121 |
41 | FES | 1.32373612 |
42 | ZAP70 | 1.32246241 |
43 | KSR2 | 1.28279454 |
44 | PBK | 1.23558455 |
45 | PDK1 | 1.23183224 |
46 | MAP3K1 | 1.22256073 |
47 | CDK4 | 1.20416019 |
48 | JAK1 | 1.17983423 |
49 | NLK | 1.17530966 |
50 | FGR | 1.16139170 |
51 | DYRK3 | 1.14753316 |
52 | STK24 | 1.14683517 |
53 | SRPK1 | 1.13669116 |
54 | CSF1R | 1.11118893 |
55 | PDK3 | 1.08854363 |
56 | PDK4 | 1.08854363 |
57 | ATR | 1.08524550 |
58 | TAOK2 | 1.08195804 |
59 | IRAK1 | 1.07760639 |
60 | EIF2AK2 | 1.06171101 |
61 | MAP3K13 | 1.05862371 |
62 | MYLK | 1.05632812 |
63 | ZAK | 1.05465269 |
64 | TGFBR1 | 1.04969380 |
65 | PDPK1 | 1.04209534 |
66 | STK16 | 1.04072079 |
67 | MST4 | 1.01789208 |
68 | SGK3 | 1.00490262 |
69 | SYK | 1.00041149 |
70 | TSSK6 | 0.94805972 |
71 | PLK1 | 0.94733899 |
72 | STK3 | 0.94487393 |
73 | AURKB | 0.94255094 |
74 | BMX | 0.91871641 |
75 | SIK3 | 0.91490953 |
76 | EPHB1 | 0.89787140 |
77 | SCYL2 | 0.88714141 |
78 | CDK7 | 0.88292807 |
79 | PTK2B | 0.87369224 |
80 | RPS6KB2 | 0.86092423 |
81 | MAPK12 | 0.85879652 |
82 | WNK1 | 0.85830535 |
83 | TAOK1 | 0.85688658 |
84 | SGK2 | 0.85204742 |
85 | HIPK2 | 0.84784407 |
86 | BRSK1 | 0.82791748 |
87 | RAF1 | 0.82611929 |
88 | CCNB1 | 0.80369278 |
89 | RIPK1 | 0.78953746 |
90 | IRAK2 | 0.78864834 |
91 | CDC42BPA | 0.76963843 |
92 | TNK2 | 0.76371772 |
93 | CDK8 | 0.75122357 |
94 | STK38 | 0.74821534 |
95 | RET | 0.72022597 |
96 | EPHA3 | 0.71919495 |
97 | ABL2 | 0.70444514 |
98 | FGFR4 | 0.70297161 |
99 | YES1 | 0.70070540 |
100 | LRRK2 | 0.70011329 |
101 | MAP2K3 | 0.69477302 |
102 | BLK | 0.69222654 |
103 | LCK | 0.68160674 |
104 | STK10 | 0.67530066 |
105 | MAPK11 | 0.66847445 |
106 | MARK2 | 0.65951949 |
107 | TAOK3 | 0.65629878 |
108 | MUSK | 0.65459733 |
109 | TTN | 0.65187637 |
110 | CAMKK1 | 0.63570569 |
111 | OBSCN | 0.62439188 |
112 | CHEK2 | 0.61862158 |
113 | BCKDK | 0.61756199 |
114 | MAPK7 | 0.60033520 |
115 | TGFBR2 | 0.59639163 |
116 | PASK | 0.59175596 |
117 | LYN | 0.58511034 |
118 | PKN2 | 0.57797856 |
119 | TRPM7 | 0.56940946 |
120 | MAP3K12 | 0.56608738 |
121 | MAP3K11 | 0.56349870 |
122 | MAP3K7 | 0.55724764 |
123 | PRKCQ | 0.53622442 |
124 | KDR | 0.52774254 |
125 | MAP3K5 | 0.52723540 |
126 | RIPK4 | 0.51935349 |
127 | MARK3 | 0.51520028 |
128 | GRK7 | 0.50910726 |
129 | GRK5 | 0.50843509 |
130 | MELK | 0.50811882 |
131 | PDGFRB | 0.50788072 |
132 | CHEK1 | 0.50690793 |
133 | MAP3K8 | 0.50601885 |
134 | JAK2 | 0.48373884 |
135 | AKT3 | 0.48020086 |
136 | EEF2K | 0.47184800 |
137 | DAPK2 | 0.47051100 |
138 | HCK | 0.46556850 |
139 | NUAK1 | 0.45900482 |
140 | FYN | 0.45685286 |
141 | MKNK1 | 0.45600498 |
142 | MATK | 0.45203904 |
143 | CDK12 | 0.45136152 |
144 | FRK | 0.45027896 |
145 | RPS6KA5 | 0.44514456 |
146 | NEK1 | 0.44081733 |
147 | CAMKK2 | 0.44057353 |
148 | CDK6 | 0.43699382 |
149 | MKNK2 | 0.43562229 |
150 | PDK2 | 0.43408217 |
151 | ITK | 0.41166706 |
152 | ATM | 0.39632321 |
153 | MAPKAPK2 | 0.37743413 |
154 | ILK | 0.33589784 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 3.63567235 |
2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.99554442 |
3 | Mismatch repair_Homo sapiens_hsa03430 | 2.64013701 |
4 | Allograft rejection_Homo sapiens_hsa05330 | 2.44607820 |
5 | Proteasome_Homo sapiens_hsa03050 | 2.36174060 |
6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.33835306 |
7 | Base excision repair_Homo sapiens_hsa03410 | 2.33114098 |
8 | Homologous recombination_Homo sapiens_hsa03440 | 2.32960175 |
9 | RNA polymerase_Homo sapiens_hsa03020 | 2.24033136 |
10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.13452669 |
11 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.08683059 |
12 | Ribosome_Homo sapiens_hsa03010 | 2.08378799 |
13 | Measles_Homo sapiens_hsa05162 | 2.07589105 |
14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.05238493 |
15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.97776249 |
16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.93357507 |
17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.89745327 |
18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.86558548 |
19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.82424240 |
20 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.81888557 |
21 | Cell cycle_Homo sapiens_hsa04110 | 1.76955231 |
22 | Legionellosis_Homo sapiens_hsa05134 | 1.71661453 |
23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.67503248 |
24 | RNA transport_Homo sapiens_hsa03013 | 1.64139182 |
25 | Influenza A_Homo sapiens_hsa05164 | 1.59035729 |
26 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.57115831 |
27 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.55363917 |
28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.54476394 |
29 | Spliceosome_Homo sapiens_hsa03040 | 1.50773294 |
30 | Basal transcription factors_Homo sapiens_hsa03022 | 1.46301815 |
31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44967342 |
32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.43398248 |
33 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.39095600 |
34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.37950307 |
35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.34819690 |
36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.31895541 |
37 | RNA degradation_Homo sapiens_hsa03018 | 1.29596741 |
38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.28105561 |
39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.27422338 |
40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.27386881 |
41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27312205 |
42 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.26616698 |
43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.25590289 |
44 | Asthma_Homo sapiens_hsa05310 | 1.23690655 |
45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.21841719 |
46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11206538 |
47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.08879966 |
48 | Apoptosis_Homo sapiens_hsa04210 | 1.07346018 |
49 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00063281 |
50 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99687863 |
51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.98103457 |
52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97160507 |
53 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.96244957 |
54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95340143 |
55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94324580 |
56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94305108 |
57 | Hepatitis B_Homo sapiens_hsa05161 | 0.94180995 |
58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94042105 |
59 | Purine metabolism_Homo sapiens_hsa00230 | 0.93540618 |
60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92484377 |
61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.91341175 |
62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87808023 |
63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87753822 |
64 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.87313727 |
65 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87070052 |
66 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.86227339 |
67 | Shigellosis_Homo sapiens_hsa05131 | 0.85843990 |
68 | Insulin resistance_Homo sapiens_hsa04931 | 0.85352296 |
69 | Pertussis_Homo sapiens_hsa05133 | 0.85119128 |
70 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.84626433 |
71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83945088 |
72 | Long-term potentiation_Homo sapiens_hsa04720 | 0.83618935 |
73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81540165 |
74 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.81248980 |
75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81010406 |
76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80628538 |
77 | Protein export_Homo sapiens_hsa03060 | 0.79326559 |
78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.78649695 |
79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77918887 |
80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.77294290 |
81 | Tuberculosis_Homo sapiens_hsa05152 | 0.77177361 |
82 | Phagosome_Homo sapiens_hsa04145 | 0.75426999 |
83 | Glioma_Homo sapiens_hsa05214 | 0.74182835 |
84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73868503 |
85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72792844 |
86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72673454 |
87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72619390 |
88 | Malaria_Homo sapiens_hsa05144 | 0.71131572 |
89 | Amoebiasis_Homo sapiens_hsa05146 | 0.69515166 |
90 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68248169 |
91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67640703 |
92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67313186 |
93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66518765 |
94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65694877 |
95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65509305 |
96 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.65385338 |
97 | Endocytosis_Homo sapiens_hsa04144 | 0.65064222 |
98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64761924 |
99 | Lysosome_Homo sapiens_hsa04142 | 0.63380435 |
100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63206227 |
101 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62697687 |
102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62322159 |
103 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61293681 |
104 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60819647 |
105 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59293966 |
106 | Renin secretion_Homo sapiens_hsa04924 | 0.58957723 |
107 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58091629 |
108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57535644 |
109 | Thyroid cancer_Homo sapiens_hsa05216 | 0.56708792 |
110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55290473 |
111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54401187 |
112 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53892627 |
113 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53503532 |
114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53276559 |
115 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.51549435 |
116 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51321730 |
117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50467040 |
118 | Hepatitis C_Homo sapiens_hsa05160 | 0.50181524 |
119 | Prostate cancer_Homo sapiens_hsa05215 | 0.49721052 |
120 | Focal adhesion_Homo sapiens_hsa04510 | 0.49487095 |
121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49154435 |
122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48945287 |
123 | ABC transporters_Homo sapiens_hsa02010 | 0.48710675 |
124 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48558501 |
125 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.47109888 |
126 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46781256 |
127 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45352149 |
128 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43330855 |
129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42979020 |
130 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.42875521 |
131 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.42152070 |
132 | Salmonella infection_Homo sapiens_hsa05132 | 0.42014271 |
133 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.41691420 |
134 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40813109 |
135 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.40784299 |
136 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40694661 |
137 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.35922243 |
138 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33513123 |
139 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32389520 |
140 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.31776562 |
141 | Other glycan degradation_Homo sapiens_hsa00511 | 0.31685518 |
142 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31131815 |
143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30838485 |
144 | Sulfur relay system_Homo sapiens_hsa04122 | 0.30630624 |
145 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.27590381 |
146 | Platelet activation_Homo sapiens_hsa04611 | 0.26999363 |
147 | Carbon metabolism_Homo sapiens_hsa01200 | 0.26978634 |
148 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.24691551 |
149 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.24473020 |